SU

Shams Uddin

Active Director Director DIN 01384725
DIN 01384725 First appointment Mar 2007 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2007
Shareholding value •••• Premium profile

About Shams Uddin

Data last updated:

Shams Uddin is a Director at Eurabia Pharmaceuticals Private Limited (since 2007). The company operates in Trading. Eurabia Pharmaceuticals Private Limited reported revenue of ₹3.1 Lakh (FY 2019).

DIN 01384725
Primary Designation Director
Industry Trading
First Appointment 15 Mar 2007
Oldest Company Age 32 yrs
Largest company Eurabia Pharmaceuticals Private Limited · ₹3.1 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20071994₹3.1 Lakh (FY 2019)Active

Board colleagues of Shams Uddin

NameDINCompanyDesignation
Matin Ahmed01382437Eurabia Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Eurabia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shams Uddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shams Uddin

Shams Uddin currently holds 1 directorship: Eurabia Pharmaceuticals Private Limited (Director, since 15 Mar 2007, revenue ₹3.1 Lakh (FY 2019)).

Shams Uddin was first appointed on 15 Mar 2007 as Director at Eurabia Pharmaceuticals Private Limited.

The current boards of Shams Uddin's companies include Matin Ahmed (Eurabia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available